mimetic

(redirected from Mimetics)
Also found in: Dictionary, Thesaurus, Medical.

mimetic

Biology of or exhibiting mimicry

mimetic

[mə′med·ik]
(crystallography)
Pertaining to a crystal that is twinned or malformed but whose crystal symmetry appears to be of a higher grade than it actually is.
(petrology)
Of a tectonite, having a deformation fabric, formed by mimetic crystallization, that reflects and is influenced by preexisting anisotropic structure.
(zoology)
Pertaining to or exhibiting mimicry.
References in periodicals archive ?
That study was followed by the June publication of a British Medical Journal investigation that found the manufacturers of Byetta and other incretin mimetics may have downplayed the drugs' potential to harm the pancreas.
In what will follow below I will first point out some of the problems that Kita's analysis faces regarding adverbial mimetics and will argue that at least some of the arguments that he advances to motivate the dichotomy of the two dimensions are not as convincing as he intends.
The research plan supported by the grant is to design small molecule peptide mimetic inhibitors that bind to a drug target site identified and validated by Dr.
These computational methods were used in the design of PolyMedix's defensin mimetic antibiotic compounds, which represent a new class of antibiotic drugs and antimicrobial biomaterials that are believed to work in such a way that makes bacterial resistance unlikely to develop.
The Provid relationship is an ideal implementation of our mission, and we look forward to the company's development of the mimetics technology.
Neurochem is using a multi-pronged approach towards the development of pharmaceuticals for Alzheimer's Disease, including glycosaminoglycans (GAGs) mimetics, a vaccine, an anti-inflammatory and a neuroprotective approach as well as the creation of a diagnostic imaging tool.
The company's SOD enzyme mimetics are well suited for use as drugs because they have a low molecular weight, are highly stable and do not appear to elicit an immune response in the body.
SOD mimetics have major medical potential, based on the growing body of antioxidant and disease research.
The report expects incretin mimetics to emerge as a major new therapeutic class in non-insulin antidiabetics, driven by an explosion in the patient population, safety fears surrounding established therapies and significant unmet patient needs.
MetaPhore has developed a proprietary family of mimetics to SOD, which are much smaller, less complex, and more stable molecules.
MetaPhore is moving its SOD mimetics forward for inflammation and pain, dermatitis, neutropenia, refractory hypotension and reperfusion injury.
The Company's scientists are experts in designing, optimizing and synthesizing mimetics for research, diagnostic and therapeutic applications.